Usefulness of clinical risk markers and ischemic threshold to stratify risk in patients undergoing major noncardiac surgery.

[1]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[2]  Jeroen J. Bax,et al.  Predictors of Cardiac Events After Major Vascular Surgery Role of Clinical Characteristics, Dobutamine Echocardiography, and b-Blocker Therapy , 2001 .

[3]  Jeroen J. Bax,et al.  The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. , 1999, The New England journal of medicine.

[4]  E F Cook,et al.  Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. , 1999, Circulation.

[5]  S. Grundy.  Primary prevention of coronary heart disease: integrating risk assessment with intervention. , 1999, Circulation.

[6]  Thomas E. Moritz,et al.  Prophylactic coronary artery revascularization for elective vascular surgery: study design. Veterans Affairs Cooperative Study Group on Coronary Artery Revascularization Prophylaxis for Elective Vascular Surgery. , 1999, Controlled clinical trials.

[7]  D. Berman,et al.  The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group. , 1999, Journal of the American College of Cardiology.

[8]  N. Kaplan.  New JNC-6 guidelines. Joint National Committee. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  S M Grundy,et al.  Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. , 1998, Circulation.

[10]  A. Wallace,et al.  Prophylactic Atenolol Reduces Postoperative Myocardial Ischemia , 1998, Anesthesiology.

[11]  L Crouse,et al.  Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. , 1998, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[12]  A. Wallace,et al.  Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. , 1996, The New England journal of medicine.

[13]  L J Shaw,et al.  Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery. , 1996, Journal of the American College of Cardiology.

[14]  R. Gibbons,et al.  Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). , 1996, Journal of the American College of Cardiology.

[15]  I. R. Thomson,et al.  Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography. , 1995, Journal of the American College of Cardiology.

[16]  D. Owens,et al.  The role of coronary angiography and coronary revascularization before noncardiac vascular surgery. , 1995, JAMA.

[17]  J R Roelandt,et al.  Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease. , 1994, The American journal of medicine.

[18]  A. Salustri,et al.  Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. , 1992, The American journal of cardiology.

[19]  G. Moneta,et al.  The incidence of perioperative myocardial infarction in general vascular surgery. , 1992, Journal of vascular surgery.

[20]  D. Mangano,et al.  Perioperative myocardial ischemia in patients undergoing noncardiac surgery--I: Incidence and severity during the 4 day perioperative period. The Study of Perioperative Ischemia (SPI) Research Group. , 1991, Journal of the American College of Cardiology.

[21]  E. Picano,et al.  Stress echocardiography and the human factor: the importance of being expert. , 1990, Journal of the American College of Cardiology.

[22]  T. Riles,et al.  Beta blockade to decrease silent myocardial ischemia during peripheral vascular surgery , 1989 .

[23]  C. Coley,et al.  Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery , 1989 .

[24]  J. Sear,et al.  Risk of myocardial ischaemia during anaesthesia in treated and untreated hypertensive patients. , 1988, British journal of anaesthesia.

[25]  N. Hertzer,et al.  Coronary Artery Disease in Peripheral Vascular Patients: A Classification of 1000 Coronary Angiograms and Results of Surgical Management , 1984, Annals of surgery.

[26]  G. Beller,et al.  Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. , 1983, Circulation.

[27]  L Goldman,et al.  Multifactorial index of cardiac risk in noncardiac surgical procedures. , 1977, The New England journal of medicine.